摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4H-吡喃-4-酮,2,3-二甲基- | 82231-60-5

中文名称
4H-吡喃-4-酮,2,3-二甲基-
中文别名
——
英文名称
Cuminyl hydroperoxide
英文别名
1-(hydroperoxymethyl)-2-propan-2-ylbenzene
4H-吡喃-4-酮,2,3-二甲基-化学式
CAS
82231-60-5
化学式
C10H14O2
mdl
——
分子量
166.22
InChiKey
IHGXYVRBCMDFET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Hydrogel Nanocompsites for Ophthalmic Applications
    申请人:Ravi Nathan
    公开号:US20070269488A1
    公开(公告)日:2007-11-22
    The present invention relates to reversible hydrogel systems. Particularly, the hydrogel of the present invention is made up of copolymers that can be a hydrogel when in an oxidized state and can be a solution when in a reduced state. A solution of the copolymer can be oxidized to form a hydrogel; and the hydrogel can be reduced to form a solution of the copolymer. Reversible nanogels can also be formed from a dilute solution of the copolymers. The hydrogel is formed with nanoparticles embedded therein to form a nanocomposite whose refractive index and modulus can be controlled by varying the amounts of nanoparticles and the polymer concentration of the hydrogel, respectively
    本发明涉及可逆凝胶系统。特别是,本发明的凝胶由共聚物组成,在氧化状态时可以是凝胶,在还原状态时可以是溶液。共聚物的溶液可以被氧化成凝胶;凝胶可以被还原成共聚物的溶液。还可以从稀溶液的共聚物形成可逆纳米凝胶。凝胶中嵌入了纳米颗粒以形成折射率和模量可以通过改变纳米颗粒的量和凝胶的聚合物浓度来控制的纳米复合材料。
  • Improved MBS impact modifier
    申请人:ROHM AND HAAS COMPANY
    公开号:EP0985692A2
    公开(公告)日:2000-03-15
    A process and composition for MBS modifiers having (A) a rubbery core, (B) an inner graft stage comprised mainly of a hard polymer, (C) an intermediate sealer stage comprised mainly of an alkyl acrylate monomer and/or a polyunsaturated crosslinker, and (D) an outer shell to provide compatibility of the core-shell polymer with the matrix polymer, is disclosed. A process for preparing MBS impact modifiers having suprisingly improved impact performance in matrix polymers is also disclosed. Articles prepared from blends of matrix polymers and the MBS core-shell polymers described herein are also disclosed.
    本发明公开了一种 MBS 改性剂的工艺和组合物,该改性剂具有 (A) 橡胶芯,(B) 主要由硬质聚合物组成的内接枝阶段,(C) 主要由丙烯酸烷基酯单体和/或多不饱和交联剂组成的中间封端阶段,以及 (D) 用于提供芯壳聚合物与基质聚合物相容性的外壳。本发明还公开了一种制备 MBS 抗冲改性剂的工艺,这种改性剂在基体聚合物中的抗冲击性能得到了惊人的改善。还公开了由基体聚合物和本文所述 MBS 芯壳聚合物的混合物制备的物品。
  • Process for the preparation of polymers having a reduced content of volatile components
    申请人:Wacker Polymer Systems GmbH & Co. KG
    公开号:US20020165341A1
    公开(公告)日:2002-11-07
    The invention relates to a process for the preparation of polymers stabilized with protective colloids in the form of water-redispersible powders or aqueous dispersions thereof having a reduced content of volatile components, by a) polymerizing by emulsion or suspension polymerization, one or more monomers from the group consisting of vinyl esters, (meth)acrylates, vinyl aromatics, olefins, 1,3-dienes and vinyl halides and optionally further monomers copolymerizable therewith, b) aftertreating the polymer dispersion thus obtained by means of postpolymerization, distillation, and/or introduction of steam or inert gas to obtain a residual content of volatile, nonaqueous components of <2000 ppm, and c) spray drying of aftertreated polymer dispersion to a residual content of volatile, nonaqueous components of <400 ppm, the dispersion being adjusted prior to spray drying to a solids content of <45% by weight before spraying, the spray drying performed with gas at an inlet temperature of >120° C., and optimally d) redispersing of the resulting powder in water.
    本发明涉及一种用保护胶体稳定的聚合物的制备工艺,其形式为可再分散的粉末 或分散体,挥发性成分含量较低,制备方法为 a) 通过乳液聚合或悬浮聚合将乙烯基酯、(甲基)丙烯酸酯、乙烯基芳烃、烯烃、1,3-二 烯和卤化乙烯基以及可与之共聚的其他单体中的一种或多种单体聚合、 b) 通过后聚合、蒸馏和/或引入蒸汽或惰性气体对由此获得的聚合物分散体进行后处理,使挥发性非成分的残留量小于 2000 ppm,以及 c) 将处理后的聚合物分散液喷雾干燥,使挥发性非成分的残留量达到 120 摄氏度,最佳方法是 d) 将得到的粉末重新分散在中。
  • Reversible hydrogel systems and methods therefor
    申请人:——
    公开号:US20040156880A1
    公开(公告)日:2004-08-12
    The present invention relates to reversible hydrogel systems for medical applications. Particularly, the hydrogel of the present invention is made up of copolymers that can be a hydrogel when in an oxidized state and can be a solution when in a reduced state. A solution of the copolymer can be oxidized to form a hydrogel; and the hydrogel can be reduced to form a solution of the copolymer. The solution can be dehydrated to produce the dry copolymer for storage. Furthermore, the present invention also relates to methods of making and using the reversible hydrogel systems.
    本发明涉及医疗应用中的可逆凝胶系统。特别是,本发明的凝胶由共聚物组成,共聚物在氧化状态下可以是凝胶,在还原状态下可以是溶液。共聚物溶液经氧化后可形成凝胶;凝胶经还原后可形成共聚物溶液。溶液可以脱,生成干的共聚物用于储存。此外,本发明还涉及可逆凝胶系统的制造和使用方法。
  • EP0985692B1
    申请人:——
    公开号:EP0985692B1
    公开(公告)日:2005-01-19
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫